PRP wrist study pulled before it even started

NCT ID NCT03830775

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study planned to test whether a platelet-rich plasma (PRP) injection, made from a patient's own blood, could help heal a common wrist ligament injury called TFCC tear. The trial was designed to compare PRP against a placebo in adults with MRI-confirmed tears. However, the study was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

platelet-rich plasma (PRP) injection

What this could lead to

If it had worked, this could have pointed toward a non-surgical treatment for common wrist ligament injuries.

What could go wrong

The trial was withdrawn before enrolling anyone, so no data exist. PRP is still unproven for this condition, and results from other joints vary widely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

familial pityriasis rubra pilaris Wrist Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lola Norton

    El Paso, Texas, 79903, United States